Skip to content

Clinical trials

Urinary Incontinence trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Incontinence Phase: Not applicable Country / region: United States Clear all

134 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20054
20062
20071
20086
20092
20106
20112
20123
20147
20156
20163
201710
20188
20197
20209
20219
20229
20239
202414
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81
Recruiting15
Unknown status11
Terminated11
Withdrawn6
Active, not recruiting6
Enrolling by invitation2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Rochester6
VA Office of Research and Development6
BTL Industries Ltd.5
Corewell Health East4
NICHD Pelvic Floor Disorders Network4
University of California, San Francisco4
Bright Uro3
C. R. Bard3
Coloplast A/S3
Johns Hopkins University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Incontinence134
Urinary Bladder, Overactive24
Urinary Incontinence, Stress23
Urinary Incontinence, Urge22
Prostatic Neoplasms13
Pelvic Floor Disorders11
Pelvic Organ Prolapse10
Fecal Incontinence8
Lower Urinary Tract Symptoms7
Nocturia6

Trials

Showing 1 to 25 of 134. Each trial links to its page on Pharma Observatory.

34 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.